Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

216
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
216
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

741
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
741
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

293
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
293
Association Areas of the Cortex01:21

Association Areas of the Cortex

6.8K
Association areas are regions of the cerebral cortex that do not have a specific sensory or motor function. Instead, they integrate and interpret information from various sources to enable higher cognitive processes such as memory, learning, and decision-making. Some key association areas include the following:
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
6.8K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

828
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
828
Dissociative Disorders01:27

Dissociative Disorders

202
Dissociative disorders represent complex psychological conditions characterized by disruptions in consciousness, memory, identity, or perception. These disruptions cause individuals to experience a disconnection from their thoughts, emotions, and memories. The phenomenon is not merely an occasional lapse in attention but a profound alteration in mental functioning that can severely impact daily life.
Dissociative Fugue
A hallmark feature of dissociative disorders is the dissociative fugue...
202

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neonatal systemic gene therapy restores cardiorespiratory function in a rat model of Pompe disease.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Patient profiles and disease characteristics of the IMSRN cohort: a multicentre study (2021-2025).

The Lancet regional health. Southeast Asia·2026
Same author

Ischemic Stroke Management in India: Insights from the Indian Registry of Stroke Care Quality.

Cerebrovascular diseases (Basel, Switzerland)·2025
Same author

Neonatal systemic gene therapy restores cardiorespiratory function in a rat model of Pompe disease.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

Comparing Stroke Profiles and Outcomes between Urban and Rural India: A Secondary Analysis of the SPRINT INDIA Trial.

Cerebrovascular diseases (Basel, Switzerland)·2025
Same author

Neonatal systemic gene therapy restores cardiorespiratory function in a rat model of Pompe disease.

bioRxiv : the preprint server for biology·2025
Same journal

A Life in Service of Neuroscience, Healing, and Teaching.

Neurology India·2026
Same journal

IN MEMORIAM.

Neurology India·2026
Same journal

Extensive Diffusion Restriction of White Matter, Midbrain, and Basal ganglia in a Neonate with Refractory Hypoglycemic Seizures.

Neurology India·2026
Same journal

CHD2-Related Developmental Epileptic Encephalopathy and Angelman Syndrome in a Girl: A Double Jeopardy.

Neurology India·2026
Same journal

Cerebral Schistosomiasis Mimicking Multiple Intracranial Metastases.

Neurology India·2026
Same journal

Extrusion of Spinal Implants Through the Overlying Skin: A Rare Epiphenomenon of Metal Allergy.

Neurology India·2026
See all related articles

Related Experiment Video

Updated: Oct 14, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.7K

Frontotemporal Dementia - Current Concepts.

Goutham Kumar Puppala1, Shankar Prasad Gorthi1, Vijay Chandran1

  • 1Department of Neurology, Kasturba Hospital, Manipal, Udupi, Karnataka, India.

Neurology India
|November 8, 2021
PubMed
Summary
This summary is machine-generated.

Frontotemporal dementia (FTD) is a common neurodegenerative disease affecting behavior and language, often underdiagnosed due to overlapping psychiatric symptoms. Early identification of behavioral variant FTD and primary progressive aphasia is crucial.

Keywords:
Behaviorexecutive function (or) languagefrontotemporal dementialanguageprimary progressive aphasia

More Related Videos

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

14.2K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

32.9K

Related Experiment Videos

Last Updated: Oct 14, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.7K
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

14.2K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

32.9K

Area of Science:

  • Neuroscience
  • Neurology
  • Geriatrics

Background:

  • Frontotemporal dementia (FTD) is a group of neurodegenerative diseases characterized by behavioral and language deficits.
  • It is a leading cause of dementia in individuals under 65.
  • FTD is frequently underdiagnosed due to symptom overlap with psychiatric disorders.

Purpose of the Study:

  • To review and synthesize existing literature on Frontotemporal dementia (FTD).
  • To highlight the diagnostic challenges and clinical subtypes of FTD, including behavioral variant FTD (Bv-FTD) and primary progressive aphasia (PPA).

Main Methods:

  • A systematic literature search was conducted using PubMed, MEDLINE, and Google Scholar.
  • Articles published in English between January 1, 1975, and 2018 were included.
  • Search terms included "frontotemporal dementia," "dementia," "cognition," "behavioral variant," and "primary progressive aphasia."

Main Results:

  • Frontotemporal dementia (FTD) presents with predominant deficits in behavior, executive function, or language.
  • The condition is a common cause of early-onset dementia (before 65 years).
  • Diagnostic challenges arise from the frequent overlap of FTD symptoms with psychiatric manifestations.

Conclusions:

  • Frontotemporal dementia (FTD) encompasses distinct clinical subtypes: behavioral variant FTD (Bv-FTD) and primary progressive aphasia (PPA).
  • Increased awareness and recognition of FTD are essential for accurate diagnosis and management.
  • Further research is needed to improve the diagnostic accuracy and understanding of FTD.